retatrutide clinical trial dose Dosing: What You Need to Know Before Taking It – Bolt Pharmacy retatrutide clinical trial weight loss

Serious Warning Signs Severe abdominal pain: Especially if sudden onset, radiating to back, or with vomiting (possible pancreatitis, occurred in 0.3% of patients) Severe vomiting: If unable to keep any fluids down for 24 hours (dehydration risk) Signs of dehydration: Dark urine, dizziness on standing, confusion, decreased urination (acute kidney injury risk) Vision changes: Blurred vision, eye pain (rare but requires evaluation) Rapid heart rate: Persistent heart rate over 100 at rest (some increase normal, average 2-4 bpm, but sustained tachycardia needs evaluation) Suicidal thoughts: Any thoughts of self-harm (under 1% occurrence but requires immediate support) Severe allergic reaction: Difficulty breathing, throat swelling, severe rash (anaphylaxis requires emergency care) Lump in neck: Especially with difficulty swallowing (thyroid concern, rare but part of class warning) Trust your instincts

Traussnigg, S

Appetite changes often begin within the first 12 weeks

Summary: Sulphur burps and diarrhoea are common gastrointestinal side effects of retatrutide, caused primarily by slowed gastric emptying and altered gut motility resulting from its triple receptor agonist activity